Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Usana Health Sciences (USNA) Invested Capital (2016 - 2026)

Usana Health Sciences has reported Invested Capital over the past 17 years, most recently at $557.6 million for Q2 2026.

  • Quarterly Invested Capital rose 0.87% to $557.6 million in Q2 2026 from the year-ago period, while the trailing twelve-month figure was $557.6 million through Apr 2026, up 0.87% year-over-year, with the annual reading at $547.1 million for FY2026, 1.44% down from the prior year.
  • Invested Capital was $557.6 million for Q2 2026 at Usana Health Sciences, up from $547.1 million in the prior quarter.
  • Over five years, Invested Capital peaked at $557.6 million in Q2 2026 and troughed at $395.1 million in Q1 2022.
  • The 5-year median for Invested Capital is $499.6 million (2023), against an average of $486.4 million.
  • Year-over-year, Invested Capital decreased 10.53% in 2022 and then rose 16.14% in 2023.
  • A 5-year view of Invested Capital shows it stood at $434.5 million in 2022, then grew by 14.62% to $498.0 million in 2023, then increased by 11.47% to $555.1 million in 2024, then fell by 4.87% to $528.1 million in 2025, then rose by 5.58% to $557.6 million in 2026.
  • Per Business Quant, the three most recent readings for USNA's Invested Capital are $557.6 million (Q2 2026), $547.1 million (Q1 2026), and $528.1 million (Q3 2025).